ARTICLE | Clinical News
Flublok: Phase III data
February 10, 2014 8:00 AM UTC
An open-label, Japanese Phase III trial in 55 healthy volunteers aged >=61 years showed that intramuscular ASP7374 had "favorable immunogenicity." Astellas and partner UMN could not be reached for det...